VP Shunt Malfunction and Etoposide Chemotherapy Documentation Template:

Patient presents today for evaluation of ventriculoperitoneal shunt malfunction and ongoing etoposide chemotherapy management.  The patient's primary diagnosis is hydrocephalus, managed with a VP shunt placement, and the secondary diagnosis is [Specify malignancy, e.g., medulloblastoma, germ cell tumor].  Current symptoms include [List symptoms, e.g., headache, nausea, vomiting, lethargy, seizures, blurred vision, papilledema, altered mental status].  These symptoms raise concern for potential shunt obstruction, infection, or overdrainage.  The patient's recent chemotherapy regimen includes etoposide, administered [Specify route and frequency, e.g., intravenously weekly].  Relevant medical history includes [List relevant history, e.g., date of VP shunt placement, previous shunt revisions, prior infections, current cancer stage, prior chemotherapy regimens, response to treatment].  Physical examination reveals [Document neurological findings, e.g., cranial nerve assessment, motor strength, reflexes, signs of increased intracranial pressure].  Differential diagnosis includes shunt malfunction, chemical meningitis related to etoposide, disease progression, or other neurological complications.  Planned diagnostic workup includes [List planned diagnostics, e.g., head CT scan, shunt series X-ray, lumbar puncture for CSF analysis if clinically indicated].  Treatment plan includes [List treatment plan, e.g., neurosurgical consultation for potential shunt revision, management of chemotherapy-related side effects, supportive care, pain management].  Patient education provided regarding symptoms of shunt malfunction, potential complications of chemotherapy, and importance of follow-up care.  CPT codes considered for today's visit include [List relevant CPT codes, e.g., 99214 for office visit, 70450 for head CT].  ICD-10 codes include [List relevant ICD-10 codes, e.g., T85.898A for other mechanical complication of VP shunt, G91.8 for other specified intracranial hypertension, C71.9 for malignant neoplasm of brain, unspecified].  Follow-up scheduled in [Specify timeframe] to reassess symptoms and monitor response to treatment.


Etoposide Chemotherapy and VP Shunt Management Documentation Template:

Patient with a history of hydrocephalus managed with a ventriculoperitoneal shunt presents today for ongoing etoposide chemotherapy for [Specify malignancy, e.g., Ewing sarcoma, lymphoma].  Current chemotherapy cycle is [Specify cycle number] and the patient reports [List chemotherapy related side effects, e.g., nausea, fatigue, myelosuppression, mucositis].  Complete blood count (CBC) reveals [Document relevant lab values, e.g., white blood cell count, absolute neutrophil count, platelet count, hemoglobin].  No signs or symptoms of VP shunt malfunction are noted at this time.  Neurological examination is stable.  The patient denies headache, vomiting, vision changes, or altered mental status.  Review of systems is otherwise unremarkable.  Etoposide administered as prescribed [Specify route and dose].  Patient education provided regarding neutropenic precautions, management of side effects, and importance of reporting any new or worsening symptoms.  ICD-10 codes include [List relevant ICD-10 codes, e.g., Z90.818 for presence of VP shunt, T45.1X5A for adverse effect of antineoplastic and immunosuppressive drugs, C80 for malignant neoplasm without specification of site].  CPT codes considered for today's visit include [List relevant CPT codes, e.g., 99213 for office visit, 96413 for chemotherapy administration].  Patient tolerated the treatment well and will return in [Specify timeframe] for the next cycle of chemotherapy and ongoing monitoring of shunt function.